Offering patients colorectal cancer screening

Journal of the National Cancer Institute

Volumn 97, Issue 5, 2005, Pages 328-329

  Church, Timothy R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Health Studies Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; CANCER SCREENING; COLORECTAL CANCER; EDITORIAL; HEALTH PROMOTION; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIGMOIDOSCOPY; CLINICAL TRIAL; COLORECTAL TUMOR; ITALY; MASS SCREENING; METHODOLOGY; NOTE; OCCULT BLOOD; POSTAL MAIL; SENSITIVITY AND SPECIFICITY; UNITED STATES;

CLINICAL TRIALS; COLORECTAL NEOPLASMS; HUMANS; ITALY; MASS SCREENING; OCCULT BLOOD; POSTAL SERVICE; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; UNITED STATES;

EID: 14544281994     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji078     Document Type: Editorial

References (7)

1. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood [erratum N Engl J Med 1993;329:672]. N Engl J Med 1993;328:1365-71.
2. Colorectal cancer test use among persons aged > or = 50 years - United States, 2001. MMWR Morb Mortal Wkly Rep 2003;52:193-6.
3. Vernon SW. Participation in colorectal cancer screening - a review. J Natl Cancer Inst 1997;89:1406-22.
4. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005; 97:347-57.
5. Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004;96:770-80.
6. Herbert C, Launoy G, Thezee Y, Maurel J, Richir B, Reaud JM, et al. Participants' characteristics in a French colorectal cancer mass screening campaign. Prev Med 1995;24:498-502.
7. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.